PMC7940350_01
The graphs show the trend of lymphocyte count (A,B), platelet count (C,D) and C-reactive protein levels (E,F) of both patients during hospitalization. At the bottom we reported the duration and the timing of treatment with glucocorticoids (GC), immunoglobulins (IVIG), and anakinra.
fped-08-624248-g0001.jpg
PMC7940350_02_fped-08-624248-g0001.jpg
F1
In <24 h, the patient was afebrile, her clinical conditions and laboratory results gradually improved (Figure 1) except for a decrease in fibrinogen levels during the first days after starting the biological treatment.
PMC7940350_02
The graphs show the trend of lymphocyte count (A,B), platelet count (C,D) and C-reactive protein levels (E,F) of both patients during hospitalization. At the bottom we reported the duration and the timing of treatment with glucocorticoids (GC), immunoglobulins (IVIG), and anakinra.
fped-08-624248-g0001.jpg
PMC7940350_02_fped-08-624248-g0001.jpg
F1
In <24 h, the patient was afebrile, her clinical conditions and laboratory results gradually improved (Figure 1) except for a decrease in fibrinogen levels during the first days after starting the biological treatment.